Emerging Infections Program

OMB Control No: 0920-0978	ICR Reference No: 201501-0920-018
Status: Historical Inactive	Previous ICR Reference No: 201402-0920-016
Agency/Subagency: HHS/CDC	Agency Tracking No: 15FZ
Title: Emerging Infections Program
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Withdrawn and continue	Conclusion Date: 01/29/2015
Retrieve Notice of Action (NOA)	Date Received in OIRA: 01/22/2015
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/2016	08/31/2016	08/31/2016
Responses	41,200	0	41,200
Time Burden (Hours)	12,319	0	12,319
Cost Burden (Dollars)	0	0	0

---

Abstract: CDC is requesting minor changes for 2015 reporting of diseases reported under the Emerging Infections Program.

---

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 24

IC Title Form No. Form Name Invasive Methicillin - Resistant - Staphylococcus aureus ABCs Case Report Form none Invasive Methicillin-Resistant Staph Att 2_ABCs Invasive Pneumococcal Disease in Children None Active Bacterial Core Surveillance (ABCs) Invasive Pneumococcal Disease in Children ABCs Neonatal Infection Expanded Tracking Form none Neonatal Tracking Att 1_ABCs Case Report Form CDC 52.15A 2015 Active Bacterial Core Surveillance (ABCs) Case Report Legionellosis ABCs Case Report none Legionellosis Case Report Att 5_FluSurv-NET Influenza Hospitalization Surveilance Project Case Report Form none FluSurv-NET Case Report Salmonella Shiga toxin producing E. coli Shigella Vibrio Yersinia Att 3_2015 Active Bacterial Core Surveillance (ABCs) Case Report Non-Bacteremic Pneumoccoccal Disease CDC 52.15A 2015 Active Bacterial Core Surveillance (ABCs) Case Report Non-Bacteremic Pneumococcal Disease Att 11_CDI Treatment Form None EIP CDI Surveillance: CDI Case Treatment Questionnaire Att 15_CDI Telephone Interview None Community-associated Clostridium difficle Infection (CDI Surveillance Health Inter Hemolytic Uremic Syndrome (HUS) Att 6_2014-15 Vaccination History Patient/Proxy Interview none Att 6_2014-15 Vaccination History Patient/Proxy Interview (English) Att 8_FluSurv-Net Project Consent Form None Verbal Consent Form Campylobacter Cryptosporidium Cyclospora Listeria monocytogenes Att16_Resistant Gram-Negative Bacilli Case Report Form None 2015 Multi-site Gram-Negative Surveillance Initiative (MuGSI) Healthcare Associated Infection Community Interface (HAIC) Case Report Att 10_CDI Case Report Form None Clostridium Difficile Infection (CDI) Surveillance Emerging Infections Program Case Report Att 14_CDI Screening Form None Screening Questions for Clostridium difficile Telephone Interview

---

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Changing Forms

Short Statement: Requesting approval of a non-substantive change to modify forms and make minor burden changes. These forms are use to conduct surveillance to determine the incidence and epidemiologic characteristics of invasive diseases.

---

Annual Cost to Federal Government: $6,872,123

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Thelma Sims 4046394771

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
		(a) It is necessary for the proper performance of agency functions;
		(b) It avoids unnecessary duplication;
		(c) It reduces burden on small entities;
		(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
		(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
		(f) It indicates the retention periods for recordkeeping requirements;
		(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
			(i) Why the information is being collected;
			(ii) Use of information;
			(iii) Burden estimate;
			(iv) Nature of response (voluntary, required for a benefit, or mandatory);
			(v) Nature and extent of confidentiality; and
			(vi) Need to display currently valid OMB control number;
		(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
		(i) It uses effective and efficient statistical survey methodology (if applicable); and
		(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date: 01/22/2015

---